Biopharmaceuticals
News Release - July 16, 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Source: GTC Biotherapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.